Terms: = Liver cancer AND ALDH2, ALDHI, 217, ENSG00000111275, ALDH-E2, P05091, MGC1806, ALDM AND Clinical Outcome
5 results:
1. Association of hepatitis B virus DNA levels with overall survival for advanced hepatitis B virus-related hepatocellular carcinoma under immune checkpoint inhibitor therapy.
An M; Wang W; Zhang J; Till BG; Zhao L; Huang H; Yang Y; Li T; Han L; Zhang X; Qin P; Wang Y; Zhang M; Cui H; Gao Q; Wang Z
Cancer Immunol Immunother; 2023 Feb; 72(2):385-395. PubMed ID: 35907016
[TBL] [Abstract] [Full Text] [Related]
2. Stereotactic radiofrequency ablation (SRFA) for recurrent colorectal liver metastases after hepatic resection.
Schullian P; Johnston EW; Putzer D; Laimer G; Waroschitz G; Braunwarth E; Amann A; Maglione M; Bale R
Eur J Surg Oncol; 2021 Apr; 47(4):866-873. PubMed ID: 33032865
[TBL] [Abstract] [Full Text] [Related]
3. Impact of spectral body imaging in patients suspected for occult cancer: a prospective study of 503 patients.
Andersen MB; Ebbesen D; Thygesen J; Kruis M; Rasmussen F
Eur Radiol; 2020 Oct; 30(10):5539-5550. PubMed ID: 32367416
[TBL] [Abstract] [Full Text] [Related]
4. Increased cumulative doses and appearance of hand-foot skin reaction prolonged progression free survival in sorafenib-treated advanced hepatocellular carcinoma patients.
Chang WT; Lu SN; Rau KM; Huang CS; Lee KT
Kaohsiung J Med Sci; 2018 Jul; 34(7):391-399. PubMed ID: 30063012
[TBL] [Abstract] [Full Text] [Related]
5. Hepatitis C virus genotypes in Korea and their relationship to clinical outcome in type C chronic liver diseases.
Han CJ; Lee HS; Kim HS; Choe JH; Kim CY
Korean J Intern Med; 1997 Jan; 12(1):21-7. PubMed ID: 9159033
[TBL] [Abstract] [Full Text] [Related]
